CUMBERLAND PHARMACEUTICALS REPORTS COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS
PRNewswire (Tue, 4-Aug 5:06 PM ET)
CUMBERLAND PHARMACEUTICALS TO ANNOUNCE COMPANY UPDATE & Q2 2026 FINANCIAL RESULTS
PRNewswire (Tue, 28-Jul 4:05 PM ET)
/C O R R E C T I O N -- Cumberland Pharmaceuticals Inc./
PRNewswire (Mon, 13-Jul 11:21 AM ET)
CUMBERLAND PHARMACEUTICALS ANNOUNCES SPECIAL DIVIDEND OF $1.50 PER SHARE
PRNewswire (Mon, 13-Jul 10:47 AM ET)
Cumberland Pharmaceuticals Closes Strategic Transaction with Apotex
PRNewswire (Wed, 1-Jul 9:01 AM ET)
PRNewswire (Fri, 26-Jun 11:00 AM ET)
RedHill Biopharma Announces Closing of Up To $19.4 Million Private Placement
PRNewswire (Mon, 22-Jun 4:10 PM ET)
RedHill Biopharma Announces Up To $19.4 Million Private Placement
PRNewswire (Thu, 18-Jun 8:00 AM ET)
PRNewswire (Tue, 9-Jun 7:00 AM ET)
RedHill Launches Enforcement of $11 Million New York Supreme Court Final Judgment Against Kukbo
PRNewswire (Mon, 8-Jun 7:00 AM ET)
Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment, which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The firm promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. Its brands include Acetadote, Caldolor, Kristalose, Sancuso, Vaprisol, and Vibativ. Geographically, the company generates revenue from China, South Korea, Russia, Mexico, Australia, and Saudi Arabia.
Cumberland Pharmaceuticals trades on the NASDAQ stock market under the symbol CPIX.
As of August 19, 2026, CPIX stock price climbed to $7.81 with 46,953 million shares trading.
CPIX has a beta of 1.33, meaning it tends to be more sensitive to market movements. CPIX has a correlation of 0.03 to the broad based SPY ETF.
CPIX has a market cap of $117.02 million. This is considered a Micro Cap stock.
In the last 3 years, CPIX traded as high as $8.45 and as low as $1.04.
The top ETF exchange traded funds that CPIX belongs to (by Net Assets): VTI, VXF, DFAS, DFMC, IWC.
CPIX has outperformed the market in the last year with a price return of +203.3% while the SPY ETF gained +20.8%. CPIX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +81.8% and +0.5%, respectively, while the SPY returned +4.4% and -0.3%, respectively.
CPIX support price is $7.09 and resistance is $8.17 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that CPIX shares will trade within this expected range on the day.
